A 3-year-old Nigerian boy was treated with phenobarbitone after having a no
nfebrile seizure. Two weeks later his urine was found to contain porphobili
nogen, indicating that latent acute intermittent porphyria had been unmaske
d by phenobarbitone. The drug was discontinued and carbamazepine was substi
tuted. The urine became free of polphobilinogen and the patient remained we
ll. In developing countries phenobarbitone is the most widely used anticonv
ulsant; it must be avoided in acute intermittent porphyria, and carbamazepi
ne may be tolerated. (C) 2001 BEA Trading Ltd.